220 related articles for article (PubMed ID: 34162850)
1. AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.
Zhang L; Zuris JA; Viswanathan R; Edelstein JN; Turk R; Thommandru B; Rube HT; Glenn SE; Collingwood MA; Bode NM; Beaudoin SF; Lele S; Scott SN; Wasko KM; Sexton S; Borges CM; Schubert MS; Kurgan GL; McNeill MS; Fernandez CA; Myer VE; Morgan RA; Behlke MA; Vakulskas CA
Nat Commun; 2021 Jun; 12(1):3908. PubMed ID: 34162850
[TBL] [Abstract][Full Text] [Related]
2. The Acidaminococcus sp. Cas12a nuclease recognizes GTTV and GCTV as non-canonical PAMs.
Jacobsen T; Liao C; Beisel CL
FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31004485
[TBL] [Abstract][Full Text] [Related]
3. Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity.
Huang H; Huang G; Tan Z; Hu Y; Shan L; Zhou J; Zhang X; Ma S; Lv W; Huang T; Liu Y; Wang D; Zhao X; Lin Y; Rong Z
BMC Biol; 2022 Apr; 20(1):91. PubMed ID: 35468792
[TBL] [Abstract][Full Text] [Related]
4. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.
Kleinstiver BP; Sousa AA; Walton RT; Tak YE; Hsu JY; Clement K; Welch MM; Horng JE; Malagon-Lopez J; Scarfò I; Maus MV; Pinello L; Aryee MJ; Joung JK
Nat Biotechnol; 2019 Mar; 37(3):276-282. PubMed ID: 30742127
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.
Murugan K; Seetharam AS; Severin AJ; Sashital DG
J Biol Chem; 2020 Apr; 295(17):5538-5553. PubMed ID: 32161115
[TBL] [Abstract][Full Text] [Related]
6. Optimization of AsCas12a for combinatorial genetic screens in human cells.
DeWeirdt PC; Sanson KR; Sangree AK; Hegde M; Hanna RE; Feeley MN; Griffith AL; Teng T; Borys SM; Strand C; Joung JK; Kleinstiver BP; Pan X; Huang A; Doench JG
Nat Biotechnol; 2021 Jan; 39(1):94-104. PubMed ID: 32661438
[TBL] [Abstract][Full Text] [Related]
7. Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.
Maule G; Casini A; Montagna C; Ramalho AS; De Boeck K; Debyser Z; Carlon MS; Petris G; Cereseto A
Nat Commun; 2019 Aug; 10(1):3556. PubMed ID: 31391465
[TBL] [Abstract][Full Text] [Related]
8. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates.
Ling X; Chang L; Chen H; Gao X; Yin J; Zuo Y; Huang Y; Zhang B; Hu J; Liu T
Mol Cell; 2021 Nov; 81(22):4747-4756.e7. PubMed ID: 34648747
[TBL] [Abstract][Full Text] [Related]
9. Improving FnCas12a Genome Editing by Exonuclease Fusion.
Wu Y; Yuan Q; Zhu Y; Gao X; Song J; Yin Z
CRISPR J; 2020 Dec; 3(6):503-511. PubMed ID: 33346706
[TBL] [Abstract][Full Text] [Related]
10. Rapid repair of human disease-specific single-nucleotide variants by One-SHOT genome editing.
Yokouchi Y; Suzuki S; Ohtsuki N; Yamamoto K; Noguchi S; Soejima Y; Goto M; Ishioka K; Nakamura I; Suzuki S; Takenoshita S; Era T
Sci Rep; 2020 Aug; 10(1):13927. PubMed ID: 32811847
[TBL] [Abstract][Full Text] [Related]
11. Application of Cas12j for
Tan LL; Heng E; Leong CY; Ng V; Yang LK; Seow DCS; Koduru L; Kanagasundaram Y; Ng SB; Peh G; Lim YH; Wong FT
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672502
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Substrate Specificity Reveals that CRISPR-Cas12a Is a Bifunctional Enzyme with Both Endo- and Exonuclease Activities.
Bhattacharya S; Agarwal A; Muniyappa K
J Mol Biol; 2024 May; 436(10):168550. PubMed ID: 38575054
[TBL] [Abstract][Full Text] [Related]
13. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
[TBL] [Abstract][Full Text] [Related]
14. Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells.
Glaser V; Flugel C; Kath J; Du W; Drosdek V; Franke C; Stein M; Pruß A; Schmueck-Henneresse M; Volk HD; Reinke P; Wagner DL
Genome Biol; 2023 Apr; 24(1):89. PubMed ID: 37095570
[TBL] [Abstract][Full Text] [Related]
15. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
[TBL] [Abstract][Full Text] [Related]
16. Efficient Genome Editing in Induced Pluripotent Stem Cells with Engineered Nucleases In Vitro.
Termglinchan V; Seeger T; Chen C; Wu JC; Karakikes I
Methods Mol Biol; 2017; 1521():55-68. PubMed ID: 27910041
[TBL] [Abstract][Full Text] [Related]
17. A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing.
Chen P; Zhou J; Wan Y; Liu H; Li Y; Liu Z; Wang H; Lei J; Zhao K; Zhang Y; Wang Y; Zhang X; Yin L
Genome Biol; 2020 Mar; 21(1):78. PubMed ID: 32213191
[TBL] [Abstract][Full Text] [Related]
18. Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing.
Bolukbasi MF; Liu P; Luk K; Kwok SF; Gupta A; Amrani N; Sontheimer EJ; Zhu LJ; Wolfe SA
Nat Commun; 2018 Nov; 9(1):4856. PubMed ID: 30451839
[TBL] [Abstract][Full Text] [Related]
19. Rational Design of Small Molecules to Enhance Genome Editing Efficiency by Selectively Targeting Distinct Functional States of CRISPR-Cas12a.
Li W; Chan C; Zeng C; Turk R; Behlke MA; Cheng X; Dong Y
Bioconjug Chem; 2020 Mar; 31(3):542-546. PubMed ID: 32119776
[TBL] [Abstract][Full Text] [Related]
20. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
